Key result
Erythrocyte adhesiveness/aggregation test shows variability comparable to established acute-phase markers after acute ischemia.
Key points are not available for this paper at this time.
The erythrocyte adhesiveness/aggregation test is a new biomarker to detect low-grade inflammation in patients with atherothrombosis. In a group of 30 individuals with an acute ischemic event, the variability of EAAT during a follow-up period was similar to those obtained for other commonly used markers of the acute phase response, suggesting the potential clinical use of this novel marker.
No takes yet. Share an insight, caveat, or question.
Sharshun et al. (2003) studied this question. The erythrocyte adhesiveness/aggregation test demonstrated variability comparable to established acute phase markers in 30 patients following an acute ischemic event.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: